A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
NCT00162071
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decided not to continue with the development program
Conditions
Cardiovascular Disease
Ischemic Heart Disease
Interventions
DRUG:
apadenoson
Sponsor
Forest Laboratories